BIOMAT Database Logo BIOMAT Database Logo

Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide. 2007

M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Periodontology, Department of Hard Tissue Engineering, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Periodontitis is an inflammatory bone disease caused by Gram-negative anaerobic bacteria. Osteoclast differentiation is regulated by the balance between receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG). The purpose of this study was to examine the mechanism of OPG production in human gingival fibroblasts (HGF) stimulated by lipopolysaccharide (LPS) from periodontopathic bacteria. The expressions of Toll-like receptor 2 (TLR-2) and TLR-4 in HGF were examined using flow-cytometry. HGF were stimulated with whole cell extracts or LPS from Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis with or without polymyxin B, a LPS inhibitor. In addition, HGF were stimulated with LPS, prostaglandin E(2) (PGE(2)), various agonists of PGE receptors (EP1, EP2, EP3 and EP4 agonists) with or without indomethacin (IND), a prostaglandin synthesis inhibitor. OPG and PGE(2) production was measured using an enzyme-linked immunosorbent assay (ELISA). HGF expressed both TLR-2 and TLR-4. Both A. actinomycetemcomitans and P. gingivalis LPS augmented OPG expression in HGF. Whole cell extracts from A. actinomycetemcomitans and P. gingivalis augmented OPG production by HGF; the augmentation was suppressed by polymyxin B. IND suppressed OPG production in LPS-stimulated HGF. PGE(2) stimulated HGF to produce OPG. EP1 and EP2 agonists, but not EP3 and EP4 agonists, increased OPG production by HGF. These results suggest that LPS-induced OPG production by HGF is regulated via EP1 and/or EP2 receptors by endogenously generated PGE(2).

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010518 Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) Pericementitis,Pericementitides,Periodontitides
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005881 Gingiva Oral tissue surrounding and attached to TEETH. Gums,Interdental Papilla,Papilla, Interdental,Gum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D051195 Toll-Like Receptor 2 A pattern recognition receptor that forms heterodimers with other TOLL-LIKE RECEPTORS. It interacts with multiple ligands including PEPTIDOGLYCAN, bacterial LIPOPROTEINS, lipoarabinomannan, and a variety of PORINS. TLR2 Receptor,Receptor, TLR2,Toll Like Receptor 2

Related Publications

M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides.
October 1996, Inflammation,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Amphotericin B augments interleukin-6 production by human gingival fibroblasts in vitro.
September 1997, In vitro cellular & developmental biology. Animal,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Effects of shinbuto and ninjinto on prostaglandin E2 production in lipopolysaccharide-treated human gingival fibroblasts.
January 2017, PeerJ,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Histamine augments cytokine-stimulated IL-11 production by human lung fibroblasts.
November 1994, Journal of immunology (Baltimore, Md. : 1950),
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Lipopolysaccharide stimulation of hyaluronate synthesis by human gingival fibroblasts in vitro.
January 1991, Archives of oral biology,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts.
August 2011, Journal of periodontal research,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts.
December 2003, Journal of periodontology,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Cyclooxygenase-2 Inhibitors Decrease Interleukin-1β-Stimulated Prostaglandin E2 and IL-6 Production by Human Gingival Fibroblasts.
December 2003, Journal of periodontology,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Preferential production of prostaglandin D2 by lipopolysaccharide stimulated human choriodecidual explants.
February 2006, Prostaglandins, leukotrienes, and essential fatty acids,
M Kiji, and T Nagasawa, and D Hormdee, and R Yashiro, and H Kobayashi, and K Noguchi, and H Nitta, and Y Izumi, and I Ishikawa
Prostaglandin F2alpha upregulates interleukin-6 production in human gingival fibroblasts.
April 2001, Journal of periodontal research,
Copied contents to your clipboard!